Regional Analysis

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa

Global Interventional Intracranial Aneurysm Devices Market – Regional Analysis

On the basis of region, the global interventional intracranial aneurysm devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, Europe interventional intracranial aneurysm devices market is expected to hold a dominant position during the forecast period, owing to the introduction of technologically advanced products by key players in the interventional intracranial aneurysm market that has been driven by the rising incidence of cerebral aneurysms in the region. For instance, in October 2019, Per-flow Medical, a company that develops solutions for complex neurovascular treatments with presence in Europe, received the CE mark approval for its Cascade Agile. At the time of coil embolization, this cascade agile improves control for tortuous and distant artery morphology. The system's distinctive net construction ensures steady blood flow while coiling and treating brain aneurysms. For the treatment of cerebral aneurysms and acute ischemic stroke, this medication is heavily marketed in Europe. Therefore, it is projected that these improvements will fuel the market expansion during the forecast period.

Furthermore, North America is also estimated to witness significant growth in the global interventional intracranial aneurysm devices market owing to the presence of well-established healthcare facilities, increasing funding, etc. are expected to drive the market growth in North America over the forecast period. For instance, Fluid Biomed, a medical device start-up company in Calgary, Alberta, Canada, announced the completion of its US$ 4.7 million seed fundraising round and the appointment of two new directors to its board of directors. In the company's oversubscribed funding round, METIS Innovative of Miami, Florida, and ShangBay Capital of Palo Alto, California, collaborated as co-leads. This funding will accelerate the company's growth and the development of a novel bio-absorbable stent to treat brain aneurysms.

Figure 2: Global Interventional Intracranial Aneurysm Devices Market (US$ Bn), by Region, 2022